Hepatology Hepatology 101 Hepatology Hepatologist Blood Research, Diseases

* Hepatology101 SEARCH *

*Filter: "Hepatology"

What Is Hepatology? Medical Conditions, Procedures & More
Hepatology is an area of medicine that focuses on diseases of the liver as well as related conditions.

Hepatology - LWW
Explore Hepatology, featuring peer‑reviewed articles, clinical studies, and the latest medical research.

Hepatology - Wikipedia
1Scope of specialty. 2History. 3Disease classification. 4Important procedures. 5See also. 6References. Toggle the table of contents. Hepatology. 42 languages. العربية.

Current Issue : Hepatology - LWW
Explore the current issue of Hepatology, featuring original peer-reviewed articles, clinical studies, and the latest research.

What Is a Hepatologist? What They Do and When to See One - WebMD
Once a branch of gastroenterology, hepatology has developed into its own medical field with its own subspecialties. Education and Training

AASLD Home | AASLD
Explore 60+ webinars and 80+ courses, like the updated 2026 Transplant Hepatology Board Review Course, to stay at the forefront of trends and lead in liver patient care.

Hepatology - Latest research and news | Nature
Hepatology is a medical specialty focusing on the structure, function, pathology and disorders of the liver, gall bladder and bile ducts.

Home Page: Journal of Hepatology
JHEP Reports will publish original papers, reviews, and letters to the Editor concerned with basic, translation and clinical research in the field of hepatology.

What Is Hepatology and What Does It Treat? - ScienceInsights
Hepatology focuses on liver, gallbladder, and bile duct conditions. Learn what hepatologists treat, how they differ from GI doctors, and when you might need one.

Hepatology | Journal | ScienceDirect.com by Elsevier
Read the latest articles of Hepatology at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature

* Hepatology101 LATEST NEWS *

                    *Filter: "Hepatology"

5 Hepatology Headlines You Missed in August 2026  HCPLive
From EASL 2026: What Hepatology Still Needs to Solve  The American Journal of Managed Care
UCHealth opens new outreach clinic for liver disease in Boulder  UCHealth
The role of primary care in response to the global liver disease syndemic: a Lancet Gastroenterology & Hepatology Commission  The Lancet
Division of Gastroenterology and Hepatology launches new podcast highlighting advances in digestive health  Penn State Health News
The Liver Doctor: A Compelling Work of Medical Narrative and Advocacy  docwirenews.com
Mirum Pharmaceuticals Names Dr. Rob Myers Chief Medical Officer  citybiz
Precision hepatology redefines transplant options for kids  Nature
Cedars-Sinai Research Identifies Drivers of Liver Disease  cedars-sinai.org
Cell type–specific paradox of autophagy and senescence in MASH: implications for precision hepatology  Frontiers
European Society for Paediatric Gastroenterology, Hepatology and Nutrition/North American Society for Pediatric Gastroenterology, Hepatology and Nutrition guidelines for treatment of functional constipation in children aged 0–18 years  Wiley Online Library
Gut bacterial metabolite linked to inflammation in liver disease  News-Medical
Global burden of metabolic dysfunction-associated steatotic liver disease, 1990–2023, and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2023  The Lancet
The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of gut health  Nature
6 Hepatology Headlines You Missed in June 2026  HCPLive

Common Rheumatological Symptoms

Joint Pain (Arthralgia) — Persistent discomfort or soreness in one or more joints caused by inflammation, wear and tear, or underlying autoimmune responses.
Morning Stiffness — Reduced joint mobility and tightness upon waking, often lasting over 30 to 60 minutes in inflammatory conditions like rheumatoid arthritis.
Joint Swelling and Edema — Visible enlargement of affected joints resulting from fluid accumulation in the synovial membrane and inflamed surrounding tissue.
Localized Warmth and Redness — Elevated temperature and erythema skin discoloration surrounding inflamed joints due to increased blood flow from localized inflammation.
Systemic Fatigue — Overwhelming exhaustion and lack of energy caused by ongoing chronic inflammatory cytokine activity throughout the body.
Raynaud's Phenomenon — Temporary color changes in fingers or toes turning white, blue, and red in response to cold or stress due to vascular spasms.
Malar or Butterfly Rash — Red or purplish facial rash spanning across the bridge of the nose and cheeks, classically associated with systemic lupus erythematosus.

Milestones in Rheumatology History

c. 400 BC: Hippocratic Corpus Coining — Hippocrates uses the term "rheuma" to describe body humors flowing into joints, establishing the early classical concept of joint inflammation.
1592: Formal Definition of Rheumatism — French physician Guillaume de Baillou introduces the modern term "rheumatism" to distinguish systemic acute arthritis from localized gout.
1800: Clinical Description of Rheumatoid Arthritis — Augustin Jacob Landré-Beauvais publishes the first detailed clinical description separating rheumatoid arthritis from gout, calling it "asthenic gout."
1859: Naming of Rheumatoid Arthritis — Sir Alfred Baring Garrod formally coins the term "rheumatoid arthritis" to clearly differentiate the inflammatory autoimmune condition from osteoarthritis and gout.
1940: Discovery of the Rheumatoid Factor — Erik Waaler discovers autoantibodies in the blood of patients with rheumatoid arthritis, laying the groundwork for serological autoimmune diagnostics.
1948: Introduction of Corticosteroid Therapy — Philip Hench and Edward Kendall demonstrate the dramatic anti-inflammatory effects of Compound E (cortisone) in treating rheumatoid arthritis, earning the Nobel Prize.
1998: Emergence of Biologic DMARDs — The FDA approves the first TNF-alpha inhibitors, ushering in the modern era of targeted biologic therapies for autoimmune rheumatic diseases.

Current Trends in Rheumatology Research

Chimeric Antigen Receptor (CAR) T-Cell Reset Therapy — Investigating engineered cellular therapies to achieve drug-free, durable clinical remissions by completely depleting pathogenic autoantibodies in severe refractory lupus and systemic sclerosis.
Selective TYK2 and Oral JAK Pathway Inhibition — Developing highly targeted, small-molecule oral inhibitors like deucravacitinib that disrupt specific cytokine signaling pathways while minimizing broader off-target side effects.
Targeted Pathogenic T-Cell and B-Cell Depletion — Evaluating novel biologics, such as rosnilimab and ianalumab, designed to selectively deplete overactive immune cell subpopulations involved in rheumatoid arthritis and Sjögren's disease.
Biomarker-Driven Precision Medicine — Utilizing pharmacogenomics and molecular biomarkers to predict individualized therapeutic responses and match systemic autoimmune conditions to specific biological mechanisms.
Subclinical Interception and Disease Prevention — Identifying seropositive individuals early using high-risk autoantibody profiles to initiate preventive targeted therapies before irreversible joint damage occurs.
Artificial Intelligence and Predictive Disease Modeling — Deploying machine learning algorithms across electronic health records and imaging modalities to forecast inflammatory flares and refine diagnostic accuracy.